Alzheimer’s Disease: Diagnosis and Access to Experimental Drugs

Baroness Nargund Excerpts

Wednesday 3rd June 2026 Lords Chamber

[Baroness Blake of Leeds (Lab)]

I am very willing to take the noble Lord’s advice, and I will seek out a copy as soon as I can after this session.

[Baroness Nargund (Lab)]

My Lords, women account for nearly two-thirds of people who suffer from Alzheimer’s disease and two-thirds of unpaid carers for those who suffer from Alzheimer’s disease, yet women tend to receive a delayed diagnosis or misdiagnosis. There are complex relationships between gender, hormones, ageing and the progression of disease. I request that my noble friend ensures that gender-specific research, diagnosis and care are embedded in the new women’s health strategy refresh, as well as the dementia framework.

[Baroness Blake of Leeds (Lab)]

I assure my noble friend that I will pass on her comments to my noble friend Lady Merron, who brought together the women’s health strategy, such an important piece of work and absolutely relevant in dealing with health inequalities and inequities. We know they exist.